Loading...
Market
Will Baltimore allocate over $100 million from settlements to addiction treatment by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Baltimore City budget documents or official announcements
Story
Investigation Reveals PHA Healthcare's Oversight Failures in Baltimore Addiction Programs Amid High Overdose Risk for Black Men Born 1951-1970
Dec 20, 2024, 02:51 PM
An investigation by the Baltimore Banner and the New York Times has revealed troubling issues surrounding addiction treatment programs in Baltimore, particularly focusing on a private vendor, PHA Healthcare. The investigation highlights the lax oversight of these programs, which have been criticized for trading free housing for treatment funds while offering inadequate support to patients. Reports indicate that Black men born between 1951 and 1970 are at the highest risk of overdose deaths, a trend observed in other major cities as well. The investigation calls for improved vetting and oversight as Baltimore prepares to allocate hundreds of millions in drug company settlements. The findings underscore the systemic failures within the addiction treatment system, raising questions about the effectiveness of harm reduction strategies and the role of public health departments in addressing these crises.
View original story
Similar markets
Other • 25%
Endo International • 25%
Teva Pharmaceuticals • 25%
Johnson & Johnson • 25%
Less than $1 billion • 25%
$1 billion to $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
More than $2 billion • 25%
Less than $500 million • 25%
More than $2 billion • 25%
$1 billion to $2 billion • 25%
$500 million to $1 billion • 25%
CVS settles • 25%
CVS not liable • 25%
Case dismissed • 25%
CVS found liable • 25%
Case dismissed • 25%
CVS found liable • 25%
CVS not found liable • 25%
Settlement reached • 25%